Articles

Vantage logo

Mustang and the bubble boy bubble

The value of Mustang Bio has tripled on data on its immune deficiency gene therapy. But investors might be too keen – and also too late.

Vantage logo

Boehringer pushes pipeline progress

The notoriously secretive German pharma company Boehringer Ingelheim has made much of a new drive towards transparency, but there are still things it would rather keep to…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.